IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling
Open Access
- 14 February 2014
- journal article
- Published by Springer Nature in Nature Communications
- Vol. 5 (1) , 3303
Abstract
Interferon regulatory factor 8 (IRF8) is known to affect the innate immune response, for example, by regulating the differentiation and function of immune cells. However, whether IRF8 can influence cardiac hypertrophy is unknown. Here we show that IRF8 levels are decreased in human dilated/hypertrophic cardiomyopathic hearts and in murine hypertrophic hearts. Mice overexpressing Irf8 specifically in the heart are resistant to aortic banding (AB)-induced cardiac hypertrophy, whereas mice lacking IRF8 either globally or specifically in cardiomyocytes develop an aggravated phenotype induced by pressure overload. Mechanistically, we show that IRF8 directly interacts with NFATc1 to prevent NFATc1 translocation and thus inhibits the hypertrophic response. Inhibition of NFATc1 ameliorates the cardiac abnormalities in IRF8(-/-) mice after AB. In contrast, constitutive activation of NFATc1 nullifies the protective effects of IRF8 on cardiac hypertrophy in IRF8-overexpressing mice. Our results indicate that IRF8 is a potential therapeutic target in pathological cardiac hypertrophy.Keywords
This publication has 47 references indexed in Scilit:
- Interferon Regulatory Factor 9 Protects Against Cardiac Hypertrophy by Targeting MyocardinHypertension, 2014
- The IRF Family Transcription Factors at the Interface of Innate and Adaptive Immune ResponsesCold Spring Harbor Symposia on Quantitative Biology, 2013
- IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptorsNature Reviews Immunology, 2006
- IRF-8/Interferon (IFN) Consensus Sequence-binding Protein Is Involved in Toll-like Receptor (TLR) Signaling and Contributes to the Cross-talk between TLR and IFN-γ Signaling PathwaysJournal of Biological Chemistry, 2006
- A Cell‐permeable NFAT Inhibitor Peptide Prevents Pressure‐Overload Cardiac HypertrophyChemical Biology & Drug Design, 2006
- Glycogen Synthase Kinase 3β Inhibits Myocardin-Dependent Transcription and Hypertrophy Induction Through Site-Specific PhosphorylationCirculation Research, 2005
- Calcineurin/NFAT Coupling Participates in Pathological, but not Physiological, Cardiac HypertrophyCirculation Research, 2004
- Nramp1-mediated Innate Resistance to Intraphagosomal Pathogens Is Regulated by IRF-8, PU.1, and Miz-1Journal of Biological Chemistry, 2003
- Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivoProceedings of the National Academy of Sciences, 2001
- A Calcineurin-Dependent Transcriptional Pathway for Cardiac HypertrophyCell, 1998